160 20. Crossman AR, Neary D. Neuroanatomy. 4th ed. Elsevier; 2010. 21. Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M. Longitudinal assessment of small fiber neuropathy: Evidence of a non-length-dependent distal axonopathy. JAMA Neurol. 2016;73(6):684-690. doi:10.1001/jamaneurol.2016.0057 22. Zhou R, Caspi RR. Ocular immune privilege. F1000 Biol Rep. 2010;2(1):1-3. doi:10.3410/B2-3 23. Brines M, Swartjes M, Tannemaat MR, et al. Corneal nerve quantification predicts the severity of symptoms in sarcoidosis patients with painful neuropathy. Technology. 2013;01(01):20-26. doi:10.1142/s2339547813500039 24. Culver DA, Dahan A, Bajorunas D, et al. Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Investig Ophthalmol Vis Sci. 2017;58(6):BIO52-BIO60. doi:10.1167/iovs.16-21291 25. Van Velzen M, Heij L, Niesters M, et al. Ara 290 for treatment of small fiber neuropathy in sarcoidosis. Expert Opin Investig Drugs. 2014;23(4):541-550. doi:10.1517/13543784.2014.892072 26. Sharma R, Kouranos V, Cooper LT, et al. Management of cardiac sarcoidosis. Eur Heart J. 2024;00:1-30. doi:10.1093/eurheartj 27. Drent M, Strookappe B, Hoitsma E, De Vries J. Consequences of Sarcoidosis. Clin Chest Med. 2015;36(4):727-737. doi:10.1016/j.ccm.2015.08.013 28. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: From symptoms to neuropathology. Brain. 2008;131(7):1912-1925. doi:10.1093/brain/awn093 29. Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-2293. doi:10.2337/dc10-1303 30. Themistocleous AC, Ramirez JD, Shillo PR, Lees JG, Selvarajah D. The Pain in Neuropathy Study ( PiNS ): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain. 2016;157:1132-1145. 31. Sène D. Small Fiber Neuropathy: Diagnosis, Causes, and Treatment. Vol 85. Société française de rhumatologie; 2018. doi:10.1016/j.jbspin.2017.11.002 32. Voortman M, Fritz D, Vogels OJM, et al. Small fiber neuropathy: A disabling and underrecognized syndrome. Curr Opin Pulm Med. 2017;23(5):447-457. doi:10.1097/MCP.0000000000000413 33. Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6). doi:10.1183/13993003.04079-2020 34. Geerts M, de Greef BTA, Sopacua M, et al. Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy. Neurology. 2021;96(20):e2534-e2545. doi:10.1212/WNL.0000000000011919 35. Raasing L, Vogels OJM, Veltkamp M, Grutters JC. Association between anti-inflammatory effect of infliximab and small fiber neuropathy symptoms in patients with sarcoidosis. Sarcoidosis, Vasc Diffus lung Dis Off J WASOG. 2022;39(4):e2022033. doi:10.36141/svdld.v39i4.12031 36. Tavee J. Peripheral neuropathy in sarcoidosis. J Neuroimmunol. 2022;368(January):577864. doi:10.1016/j.jneuroim.2022.577864 37. Tavee JO, Karwa K, Ahmed Z, Thompson N, Parambil J, Culver DA. Sarcoidosis-Associated Small Fiber Neuropathy in a Large Cohort: Clinical Aspects and Response to IVIG and Anti-TNF Alpha Treatment. Vol 126. Elsevier Ltd; 2017. doi:10.1016/j.rmed.2017.03.011 38. Voortman M, Beekman E, Drent M, Hoitsma E, De Vries J. Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the small fiber neuropathy screening list (SFNSL) in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 2018;35(4):333-341. 39. Verdugo RJ, Matamala JM, Inui K, et al. Review of techniques useful for the assessment of sensory small fiber neuropathies: Report from an IFCN expert group. Clin Neurophysiol. 10 167 10
RkJQdWJsaXNoZXIy MjY0ODMw